- Corporate Officers - S
- Saxe Jon S
Insider Trading History of Saxe Jon S
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Saxe Jon S since 2005.
This trader's CIK number is 1114914.
At the time of last reporting, Saxe Jon S was the Officer of Vistagen Therapeutics, Inc.. (stock ticker symbol VTGN).
Also see all insider trading activities at Vistagen Therapeutics, Inc..
Note that in the past
SAXE JON S also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at First Horizon Pharmaceutical Corp (SCRX) by Saxe Jon S
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2008 | SCRX | 0 | $0 | 3,750 | $79,050 | 3,750 | $0 |
2006 | SCRX | 0 | $0 | 7,500 | $163,725 | 15,000 | $0 |
Yearly summary of insider trading at Durect Corp (DRRX) by Saxe Jon S
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | DRRX | 130,000 | $87,945 | 0 | $0 | 0 | $0 |
2012 | DRRX | 27,810 | $26,217 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Insite Vision Inc (ISV) by Saxe Jon S
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2007 | ISV | 15,000 | $16,350 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Sciclone Pharmaceuticals Inc (SCLN) by Saxe Jon S
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | SCLN | 0 | $0 | 0 | $0 | 30,000 | $78,300 |
2016 | SCLN | 0 | $0 | 0 | $0 | 30,000 | $73,800 |
2015 | SCLN | 0 | $0 | 0 | $0 | 30,000 | $98,100 |
2012 | SCLN | 0 | $0 | 0 | $0 | 20,000 | $76,800 |
2011 | SCLN | 0 | $0 | 0 | $0 | 10,000 | $52,600 |
2007 | SCLN | 15,000 | $28,330 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Vistagen Therapeutics, Inc. (VTGN) by Saxe Jon S
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | VTGN | 0 | $0 | 0 | $0 | 2,500 | $3,750 |
2020 | VTGN | 30,000 | $20,700 | 0 | $0 | 0 | $0 |
2019 | VTGN | 20,000 | $25,286 | 0 | $0 | 1,375 | $2,062 |
Yearly summary of insider trading at Pdl Biopharma, Inc. (PDLI) by Saxe Jon S
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2008 | PDLI | 0 | $0 | 0 | $0 | 280,000 | $2,054,959 |
2006 | PDLI | 0 | $0 | 91,000 | $2,853,006 | 130,000 | $861,250 |
2005 | PDLI | 0 | $0 | 15,000 | $451,350 | 0 | $0 |
Insider trading activities at 6 companies by Saxe Jon S:
1. First Horizon Pharmaceutical Corp (SCRX)
2. Durect Corp (DRRX)
3. Insite Vision Inc (ISV)
4. Sciclone Pharmaceuticals Inc (SCLN)
5. Vistagen Therapeutics, Inc. (VTGN)
6. Pdl Biopharma, Inc. (PDLI)
Table 1. Insider trading of First Horizon Pharmaceutical Corp (SCRX) by Saxe Jon S
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2008-05-23 | SCRX | Sale | 3,750 | 21.08 | 79,050 |
2008-05-23 | SCRX | Option Ex | 3,750 | .00 | 0 |
2006-10-31 | SCRX | Option Ex | 15,000 | .00 | 0 |
2006-10-31 | SCRX | Sale | 7,500 | 21.83 | 163,725 |
Table 2. Insider trading of Durect Corp (DRRX) by Saxe Jon S
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-06-10 | DRRX | Buy | 25,000 | .55 | 13,725 |
2019-05-24 | DRRX | Buy | 30,000 | .63 | 18,900 |
2019-05-13 | DRRX | Buy | 9,600 | .71 | 6,777 |
2019-05-13 | DRRX | Buy | 40,400 | .69 | 28,037 |
2019-03-13 | DRRX | Buy | 3,700 | .82 | 3,019 |
2019-03-13 | DRRX | Buy | 21,300 | .82 | 17,487 |
2012-12-12 | DRRX | Buy | 15,000 | .91 | 13,620 |
2012-08-27 | DRRX | Buy | 2,810 | .96 | 2,697 |
2012-08-28 | DRRX | Buy | 5,000 | .98 | 4,900 |
2012-08-23 | DRRX | Buy | 5,000 | 1.00 | 5,000 |
Table 3. Insider trading of Insite Vision Inc (ISV) by Saxe Jon S
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2007-09-13 | ISV | Buy | 15,000 | 1.09 | 16,350 |
Table 4. Insider trading of Sciclone Pharmaceuticals Inc (SCLN) by Saxe Jon S
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-02-22 | SCLN | Option Ex | 12,700 | 2.61 | 33,147 |
2017-02-16 | SCLN | Option Ex | 17,300 | 2.61 | 45,153 |
2016-01-04 | SCLN | Option Ex | 30,000 | 2.46 | 73,800 |
2015-03-04 | SCLN | Option Ex | 30,000 | 3.27 | 98,100 |
2012-05-02 | SCLN | Option Ex | 20,000 | 3.84 | 76,800 |
2011-05-20 | SCLN | Option Ex | 10,000 | 5.26 | 52,600 |
2007-11-21 | SCLN | Buy | 5,000 | 1.89 | 9,430 |
2007-11-20 | SCLN | Buy | 10,000 | 1.89 | 18,900 |
Table 5. Insider trading of Vistagen Therapeutics, Inc. (VTGN) by Saxe Jon S
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-03-19 | VTGN | Option Ex | 2,500 | 1.50 | 3,750 |
2020-08-21 | VTGN | Buy | 30,000 | .69 | 20,700 |
2019-03-14 | VTGN | Buy | 7,920 | 1.27 | 10,090 |
2019-03-13 | VTGN | Buy | 12,080 | 1.26 | 15,196 |
2019-01-29 | VTGN | Option Ex | 1,375 | 1.50 | 2,062 |
Table 6. Insider trading of Pdl Biopharma, Inc. (PDLI) by Saxe Jon S
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2008-04-09 | PDLI | Option Ex | 120,000 | 4.25 | 510,000 |
2008-03-28 | PDLI | Option Ex | 93,200 | 9.66 | 899,939 |
2008-03-06 | PDLI | Option Ex | 20,600 | 9.66 | 198,913 |
2008-03-03 | PDLI | Option Ex | 35,360 | 9.66 | 341,436 |
2008-02-27 | PDLI | Option Ex | 10,840 | 9.66 | 104,671 |
2006-11-06 | PDLI | Option Ex | 40,000 | 6.62 | 265,000 |
2006-07-19 | PDLI | Option Ex | 30,000 | 6.62 | 198,750 |
2006-07-19 | PDLI | Option Ex | 30,000 | 6.62 | 198,750 |
2006-05-30 | PDLI | Option Ex | 30,000 | 6.62 | 198,750 |
2006-04-18 | PDLI | Sale | 5,000 | 30.01 | 150,045 |
2006-04-10 | PDLI | Sale | 5,000 | 30.58 | 152,910 |
2006-04-03 | PDLI | Sale | 10,000 | 32.78 | 327,790 |
2006-03-29 | PDLI | Sale | 5,000 | 32.01 | 160,025 |
2006-03-27 | PDLI | Sale | 5,000 | 31.25 | 156,240 |
2006-03-20 | PDLI | Sale | 10,000 | 32.24 | 322,360 |
2006-03-13 | PDLI | Sale | 10,000 | 31.72 | 317,220 |
2006-03-08 | PDLI | Sale | 5,000 | 32.12 | 160,620 |
2006-03-06 | PDLI | Sale | 5,000 | 31.37 | 156,830 |
2006-03-03 | PDLI | Sale | 5,000 | 32.00 | 160,000 |
2006-02-27 | PDLI | Sale | 5,000 | 30.71 | 153,530 |
2006-02-24 | PDLI | Sale | 5,000 | 30.00 | 150,000 |
2006-01-09 | PDLI | Sale | 6,000 | 30.88 | 185,286 |
2006-01-05 | PDLI | Sale | 5,000 | 30.00 | 150,000 |
2006-01-04 | PDLI | Sale | 5,000 | 30.03 | 150,150 |
2005-12-23 | PDLI | Sale | 10,000 | 30.00 | 300,000 |
2005-10-04 | PDLI | Sale | 5,000 | 30.27 | 151,350 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Saxe Jon S
(Officer of Vistagen Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.